Denali Therapeutics (DNLI) Operating Leases (2019 - 2026)
Denali Therapeutics' Operating Leases came in at $22.03 million for Q2 2026, down 31.4% from $32.11 million a year earlier and down 10.8% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Denali Therapeutics' Operating Leases was $27.21 million, down 25.8% from FY2024.
- Operating Leases has declined in each of the last six years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Going back by year, Operating Leases was $36.67 million in FY2024 (-18.5%), $44.98 million in FY2023 (-15.2%), $53.03 million in FY2022 (-9.4%) and $58.55 million in FY2021 (-8.8%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year-over-year, Operating Leases has declined for 26 consecutive quarters, with an average decline of 23.3% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 8.3% (Q3 2021) to 31.4% (Q2 2026).
- Business Quant data shows DNLI's Operating Leases at $24.68 million (Q1 2026), $27.21 million (Q4 2025) and $29.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Denali Therapeutics | 3.35 Bn | 3.35 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.03 Mn |
| Mar 31, 2026 | 24.68 Mn |
| Dec 31, 2025 | 27.21 Mn |
| Sep 30, 2025 | 29.69 Mn |
| Jun 30, 2025 | 32.11 Mn |
| Mar 31, 2025 | 34.45 Mn |
| Dec 31, 2024 | 36.67 Mn |
| Sep 30, 2024 | 38.85 Mn |
| Jun 30, 2024 | 40.98 Mn |
| Mar 31, 2024 | 43.03 Mn |
| Dec 31, 2023 | 44.98 Mn |
| Sep 30, 2023 | 46.89 Mn |
| Jun 30, 2023 | 48.75 Mn |
| Mar 31, 2023 | 50.55 Mn |
| Dec 31, 2022 | 53.03 Mn |
| Sep 30, 2022 | 54.98 Mn |
| Jun 30, 2022 | 55.53 Mn |
| Mar 31, 2022 | 57.09 Mn |
| Dec 31, 2021 | 58.55 Mn |
| Sep 30, 2021 | 59.99 Mn |
API Access
Denali Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();